Infectious Agents and Cancer

Papers
(The TQCC of Infectious Agents and Cancer is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
HPV prevalence and genotype distribution among women in Sanming, China: a retrospective analysis before large-scale vaccination65
Epidemiology of high-risk human papillomavirus among women of the north-central region of Ecuador: a retrospective study48
Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population39
Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses33
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation30
Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status30
Inhibitory effect and mechanism of Lactobacillus crispatus on cervical precancerous cells Ect1/E6E7 and screening of early warning factors28
HPV16/HPV58 viral load is non-linearly correlated with cervical lesions and can be used as a triage marker27
Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?26
The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review26
Mendelian randomization in cancer research: opportunities and challenges24
Correction: A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China23
Analysis of the triage value of multigene methylation testing for CIN2 + in hrHPV-positive patients23
Impact of differentiating between persistent and new infections on colposcopy referral in HPV-positive triage-negative women: results from the NTCC2 study23
Single-cell analysis reveals the regulatory role of ECT2 in HPV-driven cervical carcinogenesis process22
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma22
Investigation of the presence of cervical human papillomavirus and the distribution of preinvasive lesions in patients using immunomodulators-Inosine Pranobex22
Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis21
Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 20
Skin biopsy processing for rapid molecular diagnosis and histopathologic interpretation: application to Kaposi sarcoma in East Africa19
Precision therapeutic targets for HPV-positive cancers: an overview and new insights19
Highly sensitive deep panel sequencing of 27 HPV genotypes in prostate cancer biopsies results in very low detection rates and indicates that HPV is not a major etiological driver of this malignancy18
Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer18
CTSG may inhibit disease progression in HIV-related lung cancer patients by affecting immunosuppression18
Clinical characteristics and prognostic impact of HPV infection in head and neck cancer patients in China: a nationwide multicenter study17
Genetic and transcriptional insights reveal hepatitis C virus as a driver of kidney cancer17
Cox proportional hazard-model application: time to cervical cancer screening among women living with HIV in South Africa15
Prevalence of HPV in anal cancer: exploring the role of infection and inflammation15
Correction: Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases15
Concurrent sigmoid colon adenocarcinoma presenting with cutaneous adult T-cell leukemia/lymphoma: a rare case report15
Prognostic role of whole blood Epstein‑Barr virus DNA load in angioimmunoblastic T-cell lymphoma15
Development and validation of a multiplex qPCR method for identification of high-risk genotypes of human papillomavirus15
Differential expression and prognostic role of ACACA, ACLY, and FASN in schistosomiasis-associated versus hepatitis B virus-related liver cancer14
Methylation-specific qPCR for the EBV C promoter to quantify EBV methylation14
Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics14
Conventional therapy for genital herpesvirus and remission of HPV-related lesions: a case series14
Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes14
Mandatory preventive vaccines for infectious diseases expressing T-cell epitopes for cancer prevention13
Polygenic risk scores for cervical HPV infection, neoplasia and cancer show potential for personalised screening: comparison of two methods13
A comparative analysis of somatic mutational profiles according to HIV status among women with cervical intraepithelial neoplasia 3 (CIN3): a focus on hotspots in TP53, PIK3CA, PTEN, and EGFR12
Multiple pathogens and prostate cancer12
The viral origins of breast cancer12
Prevalence of Gardnerella vaginalis in HR HPV-positive women and its association with squamous intraepithelial lesions11
The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period11
An overview of mouse models of hepatocellular carcinoma11
Assessing the risk of high-grade squamous intraepithelial lesions (HSIL+) in women with LSIL biopsies: a machine learning-based study10
A SEER-based analysis of trends in HPV-associated oropharyngeal squamous cell carcinoma10
Primary seminal vesicle Burkitt lymphoma in a patient living with HIV undergoing radical prostate and seminal vesicle resection: a rare missed case report10
Persistence and risk factors of high-risk human papillomavirus infection among HIV positive and HIV negative tanzanian women: a cohort study10
Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer10
Correction: Utilization of cervical cancer screening services and its associated factors in Iran: a case–control study9
Investigating the expression of HERV-K env, np9, gag, and rec in bladder cancers9
Generalized structural equation modeling of demographic disparities in human papillomavirus (HPV) vaccine uptake among female schoolteachers in a middle eastern country9
Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation9
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial9
Detection of bovine leukemia virus, Epstein-Barr virus and human papillomavirus in breast cancer tissues of Egyptian patients8
Molecular triage of cervical screening samples in women 55–59 years of age: a pilot study8
Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women8
Incidence of de novo HPV infections in a previous HPV-negative group, related to use of different contraceptive methods: a retrospective cohort study8
Correction: HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study8
Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: resu8
Undifferentiated carcinoma of the liver with osteoclast-like giant cells: a case report and literature review8
Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy8
Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection8
HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-38
Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary study8
Microbiota and metabolite profiles of saliva, oral swab and cancer tissue from patients with oral squamous cell carcinoma (OSCC)8
GYPC methylation performance in detecting cervical (pre)cancer in high-risk HPV-positive women using liquid-based cervical scrapes7
High-risk human papillomavirus genotyping in cervical cancers in Tanzania7
High-risk HPV genotypes in women with abnormal cytology: a 12-year retrospective study7
Seroprevalence of human papilloma virus 6, 11, 16 and 18 among pregnant women in Mwanza-Tanzania7
Digital health technologies in medicine: evidence, artificial intelligence integration, and ethical challenges7
Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma7
Dengue virus infection and potential association with acute lymphoblastic leukemia in Egypt: a pilot study7
Impact of Epstein-Barr virus and CD lymphocytes on the prognosis of patients with advanced nasopharyngeal carcinoma7
High-risk human papillomavirus genotypes in cervical squamous cell carcinomas diagnosed in Rwanda7
Willingness to accept human papilloma virus vaccination and its associated factors among parents with eligible daughters in Addis Zemen town, Northwest Ethiopia6
Human papillomavirus genotypes in Jeddah, Saudi Arabia: prevalence and public health implications6
Human parvovirus B19 infection in malignant and benign tissue specimens of different head and neck anatomical subsites6
Prevalence of high-risk human papillomavirus genotypes and associated HIV co-infection in Cameroon: a systematic review and meta-analysis6
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation6
The epidemic of human papillomavirus virus-related oropharyngeal cancer: current controversies and future questions6
Human papillomavirus type 16 and 18 in urothelial bladder neoplasms: detection, quantification, and comparison with non-neoplastic samples6
Real-world clinical features and survival outcomes in diffuse large B-cell lymphoma patients with hepatitis B virus infection6
An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infecti6
Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequenc6
Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic6
Tumor-infiltrating CD4+ CD25+ FOXP3+ Treg is associated with plasma EBV DNA and disease progression in nasopharyngeal carcinoma6
Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly6
CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance6
Distribution patterns of human papillomavirus genotypes among women in Guangzhou, China6
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded6
0.15456509590149